Pressure-induced expression of vascular neuronal nitric oxide synthase: Adaptive or maladaptive response in arteries?

Journal of Hypertension

Volumn 21, Issue 5, 2003, Pages 863-865

  Touyz, Rhian M ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; MITOGEN ACTIVATED PROTEIN KINASE 1; NITRIC OXIDE SYNTHASE;

BRAIN BLOOD VESSEL; CAROTID ARTERY; ENZYME ACTIVITY; HUMAN; HYPERTENSION; INFUSION; INTRACRANIAL PRESSURE; MOLECULAR BIOLOGY; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

EID: 0037975670     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200305000-00006     Document Type: Note

References (36)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288:373-376.
2. Ignarro LJ, Buga GM, Wei LH, Bauer PM, Wu G, del Soldato P. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA 2001; 98:4202-4208.
3. Lloyd-Jones DM, Bloch KD. The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med 1996; 47:365-375.
4. Yah CY, Kim D, Aizawa T, Berk BC. Functional interplay between angiotensin II and nitric oxide. Cyclic GMP as a key mediator. Arterioscler Thromb Vasc Biol 2003; 23:26-36.
5. Soubrier F. Nitric oxide synthase genes, Candidate genes among many others. Hypertension 1999; 33:924-926.
6. Huang PL. Mouse models of nitric oxide synthase deficiency. J Am Soc Nephrol 2000; 11:S120-S123.
7. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol 2003; 284:R1-R12.
8. Cheah LS, Gwee M, Ds R, Ballard H, Yang YF, Daniel EE, Kwan CY. Evidence for the existence of a constitutive nitric oxide synthase in vascular smooth muscle. Clin Exp Pharmacol Physiol 2002; 29: 725-727.
9. Rao KM. Molecular mechanisms regulating iNOS expression in various cell types. J Toxicol Environ Health B Crit Rev 2000; 3:27-58.
10. Albrecht EW, Stegeman CA, Heeringa P, Henning RH, van Goor H. Protective role of endothelial nitric oxide synthase. J Pathol 2003; 199:8-17.
11. Ebrahimian T, Mathieu E, Sitvestre JS, Boulanger CM. Intraluminal pressure increases vascular neuronal NOS expression. J Hypertens 2003; 21:937-942.
12. Maxwell AJ. Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases. Nitric Oxide 2002; 6:101-124.
13. Klahr S. The role of nitric oxide in hypertension and renal disease progression. Nephrol Dial Transplant 2001; 16:60-62.
14. Ouvina SM, La Greca RD, Zanaro NL, Palmer L, Sassetti B. Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients. Thromb Res 2001; 102:107-114.
15. Huang PL, Lo EH. Genetic analysis of NOS isoforms using nNOS and eNOS knockout animals. Prog Brain Res 1998; 118:13-25.
16. Crespo MJ, Escobales N, Rodriguez-Sargent C. Endothelial dysfunction in the San Juan hypertensive rat: possible role of the nitric oxide synthase. J Cardiovasc Pharmacol 1996; 27:802-808.
17. Arnal JF, Dinh-Xuan AT, Pueyo M, Darblade B, Rami J. Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci 1999; 55:1078-1087.
18. Boulanger CM, Heymes C, Benessiano J, Geske RS, Levy BI, Vanhoutte PM. Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension. Circ Res 1998; 83:1271-1278.
19. Briones AM, Alonso MJ, Marin J, Balfagon G, Salaices M. Influence of hypertension on nitric oxide synthase expression and vascular effects of lipopolysaccharide in rat mesenteric arteries. Br J Pharmacol 2000; 131:185-194.
20. Kimoto-Kinoshita S, Nishida S, Tomura TT. Decrease of endothelial nitric oxide synthase in stroke-prone spontaneously hypertensive rat cerebral cortex. Neurosci Lett 2000; 288:103-106.
21. Welch WJ, Tojo A, Wilcox CS. Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR. Am J Physiol Renal Physiol 2000; 278:F769-F776.
22. Wallerath T, Witte K, Schafer SC, Schwarz PM, Prellwitz W, Wohlfart P, et al. Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci USA 1999; 96:13357-13362.
23. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377:239-242.
24. Xiao S, Wagner L, Schmidt RJ, Baylis C. Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease. Kidney Int 2001; 59:1466-1472.
25. Piech A, Dessy C, Havaux X, Feron O, Balligand JL. Differential regulation of nitric oxide synthases and their allosteric regulators in heart and vessels of hypertensive rats. Cardiovasc Res 2003; 57:456-467.
26. Sullivan JC, Pollock DM, Pollock JS. Altered nitric oxide synthase 3 distribution in mesenteric arteries of hypertensive rats. Hypertension 2002; 39:597-602.
27. Vaziri ND, Ni Z, Oveisi F. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 1998; 31:1248-1254.
28. Coffey MJ, Coles B, O'Donnell VB. Interactions of nitric oxide-derived reactive nitrogen species with peroxidases and lipoxygenases. Free Radic Res 2001; 35:447-464.
29. Touyz RM. Oxidative stress in vascular damage in hypertension. Curr Hypertens Reports 2000; 2:98-105.
30. Wang DS, Proffit D, Tsao PS. Mechanotransduction of endothelial oxidative stress induced by cyclic strain. Endothelium 2001; 8:283-291.
31. Mangiarua EI, Galagedera NJ, Patterson JR. Increased intraluminal pressure induces DNA synthesis and c-fos expression in perfused rat aorta. Arch Physiol Biochem 1996; 104:838-844.
32. Lauth M, Berger MM, Cattaruzza M, Hecker M. Pressure-induced upregulation of preproendothelin-1 and endothelin B receptor expression in rabbit jugular vein in situ: implications for vein graft failure? Arterioscler Thromb Vasc Biol 2000; 20:96-103.
33. Lauth M, Berger MM, Cattaruzza M, Hecker M. Elevated perfusion pressure upregulates endothelin-1 and endothelin B receptor expression in the rabbit carotid artery. Hypertension 2000; 35:648-654.
34. Raij L. Hypertension and cardiovascular risk factors: role of the angiotensin II-nitric oxide interaction. Hypertension 2001; 37:767-773.
35. Moreno C, Lopez A, Llinas MT, Rodriguez F, Lopez-Farre A, Nava E, Salazar FJ. Changes in NOS activity and protein expression during acute and prolonged Ang II administration. Am J Physiol 2002; 282:R31-R37.
36. Tambascia RC, Fonseca PM, Corat PD, Moreno H Jr, Saad MJ, Franchini KG. Expression and distribution of NOS1 and NOS3 in the myocardium of angiotensin II-infused rats. Hypertension 2001; 37:1423-1428.